Rowan Kuiper

1.7k total citations
36 papers, 920 citations indexed

About

Rowan Kuiper is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Rowan Kuiper has authored 36 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 26 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Rowan Kuiper's work include Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (21 papers) and Peptidase Inhibition and Analysis (8 papers). Rowan Kuiper is often cited by papers focused on Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (21 papers) and Peptidase Inhibition and Analysis (8 papers). Rowan Kuiper collaborates with scholars based in Netherlands, United States and Germany. Rowan Kuiper's co-authors include Pieter Sonneveld, Mark van Duin, Bronno van der Holt, Hartmut Goldschmidt, Laila el Jarari, Annemiek Broyl, Gareth J. Morgan, Yvonne de Knegt, Henk M. Lokhorst and Martin H. van Vliet and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Rowan Kuiper

30 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rowan Kuiper Netherlands 13 689 629 499 76 67 36 920
Homare Eda United States 13 364 0.5× 815 1.3× 480 1.0× 62 0.8× 28 0.4× 29 1.0k
Yvonne de Knegt Netherlands 7 543 0.8× 539 0.9× 330 0.7× 63 0.8× 9 0.1× 14 762
Ya‐Huei Kuo United States 15 357 0.5× 579 0.9× 235 0.5× 94 1.2× 13 0.2× 44 930
MB Kastan United States 11 226 0.3× 390 0.6× 303 0.6× 95 1.3× 21 0.3× 18 757
Marloes E.C. Broekmans Netherlands 11 289 0.4× 302 0.5× 334 0.7× 41 0.5× 173 2.6× 13 723
Ellen Wei Canada 10 250 0.4× 425 0.7× 156 0.3× 176 2.3× 20 0.3× 26 664
Zhihong Zeng United States 6 203 0.3× 467 0.7× 111 0.2× 119 1.6× 11 0.2× 13 652
Ivana Catacchio Italy 13 242 0.4× 310 0.5× 204 0.4× 55 0.7× 17 0.3× 15 561
Paolo Ditonno Italy 9 258 0.4× 239 0.4× 201 0.4× 25 0.3× 19 0.3× 15 470

Countries citing papers authored by Rowan Kuiper

Since Specialization
Citations

This map shows the geographic impact of Rowan Kuiper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowan Kuiper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowan Kuiper more than expected).

Fields of papers citing papers by Rowan Kuiper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowan Kuiper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowan Kuiper. The network helps show where Rowan Kuiper may publish in the future.

Co-authorship network of co-authors of Rowan Kuiper

This figure shows the co-authorship network connecting the top 25 collaborators of Rowan Kuiper. A scholar is included among the top collaborators of Rowan Kuiper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowan Kuiper. Rowan Kuiper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruinink, Davine Hofste op, Rowan Kuiper, Mark van Duin, et al.. (2022). Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. Journal of Clinical Oncology. 40(27). 3132–3150. 16 indexed citations
2.
Kuiper, Rowan, Victoria Wright, Dominic Habgood-Coote, et al.. (2022). Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay. Pediatric Research. 93(3). 559–569. 2 indexed citations
3.
Mutsaers, Pim, Hayri E. Balcıoğlu, Rowan Kuiper, et al.. (2021). V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma. Cancers. 13(9). 2219–2219. 12 indexed citations
4.
Verkleij, Christie P.M., Marloes E.C. Broekmans, Mark van Duin, et al.. (2021). Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma. Blood Advances. 5(8). 2196–2215. 117 indexed citations
5.
Beers, Erik H. van, et al.. (2020). Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma. Journal of Molecular Diagnostics. 23(1). 120–129. 14 indexed citations
6.
Chen, Yanting, Erik H. van Beers, Rowan Kuiper, et al.. (2019). Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients. Clinical Lymphoma Myeloma & Leukemia. 19(10). e60–e61. 3 indexed citations
7.
Kuiper, Rowan, Annemiek Broijl, Martin H. van Vliet, et al.. (2019). PS1374 PROGNOSIS IN ELDERLY MULTIPLE MYELOMA PATIENTS IN THE HOVON-87/NMSG-18 STUDY BASED ON REVISED ISS AND SKY92-ISS. HemaSphere. 3(S1). 628–629. 2 indexed citations
8.
Verkleij, Christie P.M., Marloes E.C. Broekmans, Mark van Duin, et al.. (2019). Preclinical evaluation of the new GPRC5DxCD3 (JNJ-7564) bispecific antibody for the treatment of multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e122–e123. 5 indexed citations
9.
Bruinink, Davine Hofste op, Vincent van der Velden, Mark van Duin, et al.. (2017). The Level of Circulating Myeloma Cells at Diagnosis Correlates with a Plasma Cell Leukemia-like Phenotype of the Corresponding Myeloma Cells in Bone Marrow. Blood. 130. 4368–4368.
10.
Beers, Erik H. van, Martin H. van Vliet, Rowan Kuiper, et al.. (2017). Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 17(9). 555–562. 31 indexed citations
11.
Magrangeas, Florence, Rowan Kuiper, Hervé Avet‐Loiseau, et al.. (2016). A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma. Clinical Cancer Research. 22(17). 4350–4355. 30 indexed citations
12.
Kuiper, Rowan, Mark van Duin, Martin H. van Vliet, et al.. (2015). Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System. Blood. 126(17). 1996–2004. 77 indexed citations
13.
Wu, Ping, Brian A. Walker, Annemiek Broyl, et al.. (2014). A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue. Leukemia & lymphoma. 56(3). 594–601. 5 indexed citations
14.
Kuiper, Rowan, Martin H. van Vliet, Erik H. van Beers, et al.. (2014). Prediction of High and Low-Risk Multiple Myeloma Based on the EMC92 Gene Expression Signature and the International Staging System. Blood. 124(21). 3358–3358. 1 indexed citations
15.
Kuiper, Rowan, Annemiek Broyl, Yvonne de Knegt, et al.. (2012). A gene expression signature for high-risk multiple myeloma. Leukemia. 26(11). 2406–2413. 198 indexed citations
16.
Broyl, Annemiek, Rowan Kuiper, Mark van Duin, et al.. (2012). Relation Between Cereblon Expression and Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Thalidomide. Blood. 120(21). 3973–3973.
17.
Corthals, Sophie L., Rowan Kuiper, David C. Johnson, et al.. (2011). Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients. Haematologica. 96(11). 1728–1732. 45 indexed citations
18.
Broyl, Annemiek, Sophie L. Corthals, Joost L.M. Jongen, et al.. (2010). Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial. The Lancet Oncology. 11(11). 1057–1065. 173 indexed citations
19.
Kuiper, Rowan, Sophie L. Corthals, Payman Hanifi‐Moghaddam, et al.. (2009). Developing a SNP Classifier for Predicting Peripheral Neuropathy by Bortezomib in Multiple Myeloma Patients.. Blood. 114(22). 1800–1800.
20.
Pedotti, Paola, Peter A.C. ’t Hoen, Erno Vreugdenhil, et al.. (2008). Can subtle changes in gene expression be consistently detected with different microarray platforms?. BMC Genomics. 9(1). 124–124. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Homare Eda Breakdown of academic impact, for papers by Yvonne de Knegt Breakdown of academic impact, for papers by Ya‐Huei Kuo Breakdown of academic impact, for papers by MB Kastan Breakdown of academic impact, for papers by Marloes E.C. Broekmans Breakdown of academic impact, for papers by Ellen Wei Breakdown of academic impact, for papers by Zhihong Zeng Breakdown of academic impact, for papers by Ivana Catacchio Breakdown of academic impact, for papers by Paolo Ditonno
Rankless by CCL
2026